Skip to content
Recall Observatory FDA recall evidence

Drug product

Vaniqa (eflornithine hydrochloride) Cream, 13.9% For Topical Use Only Net wt. 1.59 oz (45 g) Rx only NDC 0023-4857-45 Manufactured for Allegan, Inc. Irvine, CA 92612

D-0414-2021

March 15, 2021

Class II

Product summary

Firm
Cardinal Health Inc.
Event
Event 87512
Status
Terminated
Classification
Class II
Quantity
72 tubes
Official record key
drug-enforcement:D-0414-2021

Official wording

Reason: CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Code information: 113780

Distribution pattern: FL, GA, SC

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations